Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Stem Cells Lenses** is an investigational, locally administered cell-based ocular therapy developed by Guangdong ProCapZoom Biosciences for chronic ocular graft-versus-host disease. The product consists of therapeutic lenses loaded with human umbilical cord mesenchymal stem cells and is designed to place the cells directly at the ocular surface. Its proposed activity is local paracrine immunomodulation intended to reduce donor T-cell-mediated injury to ocular tissues after allogeneic hematopoietic stem-cell transplantation. A registered single-dose Phase 1 study evaluated four consecutive days of lens wear in three participants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stem Cells Lenses.